Zhou et al. found that cancer-associated fibroblasts (CAFs) could transfer circZFR into HCC cells, restraining the STAT3/NF-κB pathway and promoting HCC development and chemoresistance (Zhou et al., 2022). The gene discussed is STAT3; the disease is hepatocellular carcinoma.